Pronota is developing novel diagnostic products addressing significant unmet medical needs in cardio-renal syndrome and women’s health.
These products have been discovered through our unique ability to analyse comprehensively the vast range of proteins in blood, identifying those whose level correlates well with disease state, disease risk or disease prognosis.
VIB Bio-Incubator
Technologiepark 4
B-9052 Zwijnaarde / Ghent
Belgium
tel. +32 (0)9 241 11 64
fax. +32 (0)9 241 11 69
email. info@pronota.com
Pronota announces EUR 3.7 million Series C financing; management and board changes